Known targets — ChEMBL curated mechanism
ADRB1ADRB2ATP4AATP4BAXLCHRM2CHRM3DRD2FLT3HRH1HTR2AHTR2BHTR2CKCNH2KMT2AMAP2K1MAP2K2MEN1MLNRPLK4RENS1PR1SLC6A2SLC6A4atpAatpBatpCatpDatpEatpFatpFHatpGpol
The experimentally established mechanism targets of Benzodiazepine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 known ✓ | O00255 | 2/20 | 0.31 |
| ▸ | KMT2A known ✓ | Q03164 | 2/20 | 0.31 |
| ▸ | HCAR2 | Q8TDS4 | 2/20 | 0.34 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.34 |
| ▸ | TNKS | O95271 | 1/20 | 0.34 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.34 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.34 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.34 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.34 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.34 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.34 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.34 |
| ▸ | TNKS2 | Q9H2K2 | 1/20 | 0.34 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.34 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.34 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.33 |
| ▸ | MAPT | P10636 | 5/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Benzodiazepine SCHEMBL5332062 | 1.00 | HCAR2 (0.34) | HCAR2HDAC3TNKSHDAC4HDAC1 | |
| Benzodiazepine SCHEMBL11045806 | 1.00 | HCAR2 (0.34) | HCAR2HDAC3TNKSHDAC4HDAC1 | |
| Benzodiazepine SCHEMBL8133516 | 0.98 | HCAR2 (0.33) | HCAR2HDAC3TNKSHDAC4HDAC1 | |
| Benzodiazepine SCHEMBL8133521 | 0.98 | HCAR2 (0.33) | HCAR2HDAC3TNKSHDAC4HDAC1 | |
| Benzodiazepine SCHEMBL8659716 | 0.91 | HDAC3 (0.31) | HCAR2HDAC3TNKSHDAC4HDAC1 | |
| Benzodiazepine SCHEMBL10694670 | 0.90 | MAPT (0.38) | ALDH1A1MAPTGAAKDM4EMEN1 | |
| Benzodiazepine SCHEMBL11469198 | 0.89 | MAPT (0.36) | MAPTGAA | |
| Benzodiazepine SCHEMBL14740757 | 0.87 | MAPT (0.35) | MAPTGAALMNACYP2C19RECQL | |
| Benzodiazepine SCHEMBL29151800 | 0.87 | MAPT (0.35) | MAPTGAA | |
| Benzodiazepine SCHEMBL1574261 | 0.85 | MAPT (0.36) | MAPTGAALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2007149728-A2 | ARYL AND HETEROARYL TETRAHYDROBENZAZEPINE DERIVATIVES AND THEIR USE FOR TREATING GLAUCOMA | ALCON RESEARCH, LTD. (US) | 2007-12-27 | — | — | WO | claimed |
| CN-1033327-C | Process for preparing tricyclotriazolo derivatives and their use | TORAY INDUSTRIES (JP) | 1996-11-20 | — | — | CN | disclosed |